Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma.
Xuejun XuYifeng GaoShanzhou DuanQifeng DingXiaofan WangXiaoxiao DaiYongsheng ZhangYongbing ChenDonglai ChenPublished in: Cancer medicine (2023)
The presence of TLS was an independent favorable factor for patients with stage I LUAD. The presence TLS was featured by special immune profiles which might aid oncologists in determining personalized adjuvant treatment.